Kurs Legion Metals Corp Canadian Securities Exchange
Aktien
CA52490L1013
Pharmazeutika
Umsatz 2022 | 4.41 Mio. 3.26 Mio. 2.93 Mio. | Umsatz 2023 | 8.18 Mio. 6.04 Mio. 5.44 Mio. | Marktwert | 9.67 Mio. 7.14 Mio. 6.43 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2022 | -3 Mio. -2.22 Mio. -2 Mio. | Nettoergebnis 2023 | - 0 0 | EV / Sales 2022 | 2.66 x |
Nettoschuld 2022 | 984’828 727’463 655’255 | Nettoliquidität 2023 | 409’153 302’229 272’230 | EV / Sales 2023 | 1.13 x |
KGV 2022 |
-2.5
x | KGV 2023 |
41
x | Beschäftigte | - |
Rendite 2022 * |
-
| Rendite 2023 |
-
| Streubesitz | 94.84% |
Manager | Titel | Alter | Seit |
---|---|---|---|
Emma Andrews
CEO | Chief Executive Officer | - | 01.06.18 |
Sam Kassem
DFI | Director of Finance/CFO | - | 31.05.22 |
Catherine Marion
COO | Chief Operating Officer | - | - |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Fred Bonner
BRD | Director/Board Member | 62 | 14.03.19 |
Emma Andrews
CEO | Chief Executive Officer | - | 01.06.18 |
Sherry Boodram
BRD | Director/Board Member | - | 16.10.19 |
% 1. Jan. | Kap. | |
---|---|---|
+35.08% | 701 Mrd. | |
+26.24% | 571 Mrd. | |
+0.99% | 381 Mrd. | |
+20.91% | 334 Mrd. | |
+16.96% | 319 Mrd. | |
+0.74% | 210 Mrd. | |
+2.95% | 210 Mrd. | |
-6.05% | 201 Mrd. | |
-2.81% | 157 Mrd. |